have demonstrated that elevated MYBL2 expression correlates with metastasis, poorer disease-free survival, and shorter overall survival in breast cancer, highlighting how increased MYBL2 expression contributes to the disease’s enhanced invasiveness (22, 23). Here, MYBL2 is linked to breast carcinoma.